Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios alone or combined with prostate-specific antigen for the diagnosis of prostate cancer and clinically significant prostate cancer

OBJECTIVE: We evaluated whether the blood parameters before prostate biopsy can diagnose prostate cancer (PCa) and clinically significant PCa (Gleason score [GS] ≥7) in our hospital. METHODS: This study included patients with increased prostate-specific antigen (PSA) up to 20 ng/mL. The associations...

Descripción completa

Detalles Bibliográficos
Autores principales: Nepal, Sat Prasad, Nakasato, Takehiko, Fukagai, Takashi, Ogawa, Yoshio, Nakagami, Yoshihiro, Shichijo, Takeshi, Morita, Jun, Maeda, Yoshiko, Oshinomi, Kazuhiko, Unoki, Tsutomu, Noguchi, Tetsuo, Inoue, Tatsuki, Kato, Ryosuke, Amano, Satoshi, Mizunuma, Moyuru, Kurokawa, Masahiro, Tsunokawa, Yoshiki, Yasuda, Sou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Second Military Medical University 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10023529/
https://www.ncbi.nlm.nih.gov/pubmed/36942115
http://dx.doi.org/10.1016/j.ajur.2022.02.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10023529/
https://www.ncbi.nlm.nih.gov/pubmed/36942115
http://dx.doi.org/10.1016/j.ajur.2022.02.007

Ejemplares similares